US20040242583A1 - Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use - Google Patents

Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use Download PDF

Info

Publication number
US20040242583A1
US20040242583A1 US10/760,509 US76050904A US2004242583A1 US 20040242583 A1 US20040242583 A1 US 20040242583A1 US 76050904 A US76050904 A US 76050904A US 2004242583 A1 US2004242583 A1 US 2004242583A1
Authority
US
United States
Prior art keywords
alkyl
phenyl
agonists
aryl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/760,509
Inventor
Stefan Petry
Karl-Heinz Barimghaus
Norbert Tennagels
Guenter Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE2003101788 priority Critical patent/DE10301788B4/en
Priority to DE10301788.7-41 priority
Priority to US47875603P priority
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Priority to US10/760,509 priority patent/US20040242583A1/en
Assigned to AVENTIS PHARMA DEUTSCHLAND GMBH reassignment AVENTIS PHARMA DEUTSCHLAND GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MUELLER, GUENTER, TENNAGELS, NORBERT, BARINGHAUS, KARL-HEINZ, PETRY, STEFAN
Publication of US20040242583A1 publication Critical patent/US20040242583A1/en
Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AVENTIS PHARMA DEUTSCHLAND GMBH
Application status is Abandoned legal-status Critical

Links